{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T21:59:54Z","timestamp":1774389594625,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":709,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National High Technology Research and Development Program of China","award":["2011AA020105"],"award-info":[{"award-number":["2011AA020105"]}]},{"name":"Key Program of National Natural Science Foundation of China","award":["81230013"],"award-info":[{"award-number":["81230013"]}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.bbmt.2013.01.026","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T00:23:57Z","timestamp":1360023837000},"page":"777-783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Nonmalignant Late Effects in Survivors of Partially Matched Donor Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"19","author":[{"given":"Xiao-Dong","family":"Mo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai-Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2013.01.026_bib1","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2009.25.6693","article-title":"Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation","volume":"28","author":"Martin","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2013.01.026_bib2","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","article-title":"Long-term survival and late deaths after allogeneic hematopoietic cell transplantation","volume":"29","author":"Wingard","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2013.01.026_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/bmt.2009.92","article-title":"High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study","volume":"45","author":"Bresters","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.026_bib4","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood-2009-06-229369","article-title":"Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study","volume":"116","author":"Sun","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.026_bib5","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1200\/JCO.2005.12.674","article-title":"Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls","volume":"23","author":"Syrjala","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2013.01.026_bib6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1365-2141.1997.1262940.x","article-title":"Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Mo\u00eblle (SFGM)","volume":"97","author":"Soci\u00e9","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.01.026_bib7","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3324\/haematol.12949","article-title":"Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation","volume":"93","author":"Tichelli","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.01.026_bib8","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood-2006-05-022335","article-title":"Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study","volume":"109","author":"Baker","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.026_bib9","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/cncr.10773","article-title":"High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases","volume":"95","author":"Tauchmanov\u00e0","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2013.01.026_bib10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bmt.1705445","article-title":"Haploidentical hematopoietic stem cell transplantation without in\u00a0vitro T cell depletion for the treatment of hematological malignancies","volume":"38","author":"Huang","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.026_bib11","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","article-title":"Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation","volume":"107","author":"Lu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.026_bib12","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/bmt.2011.250","article-title":"Patients receiving HLA-haploidentical\/partially matched related allo-HSCT can achieve desirable HRQoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT","volume":"47","author":"Mo","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.026_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbmt.2008.11.025","article-title":"Treatment of acute leukemia with unmanipulated HLA mismatched\/haploidentical blood and bone marrow transplantation","volume":"15","author":"Huang","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.026_bib14","first-page":"1031","article-title":"A\u00a0clinical analysis of HLA-identical hematopoietic stem cell transplantation for severe aplastic anemia","volume":"48","author":"Chen","year":"2009","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.bbmt.2013.01.026_bib15","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/bmt.2012.79","article-title":"A\u00a0novel protocol for haploidentical hematopoietic SCT without in\u00a0vitro T-cell depletion in the treatment of severe acquired aplastic anemia","volume":"47","author":"Xu","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.026_bib16","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.V97.5.1196","article-title":"How I treat chronic graft-versus-host disease","volume":"97","author":"Vogelsang","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.026_bib17","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1158\/1078-0432.CCR-09-0691","article-title":"Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies","volume":"15","author":"Xiao-Jun","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2013.01.026_bib18","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.026_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbmt.2005.09.012","volume":"12","author":"Rizzo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.026_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1200\/JCO.2011.38.4594","article-title":"Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation","volume":"30","author":"Khera","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2013.01.026_bib21","article-title":"Heart failure after allogeneic hematopoietic stem cell transplantation","author":"Mo","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.bbmt.2013.01.026_bib22","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/bmt.2009.359","article-title":"Regression modeling of competing risk using R: an in depth guide for clinicians","volume":"45","author":"Scrucca","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.026_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MD.0b013e31812f864d","article-title":"A\u00a0prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation","volume":"86","author":"Leung","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbmt.2013.01.026_bib24","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1182\/blood-2002-07-2231","article-title":"Nonmalignant late effects after allogeneic stem cell transplantation","volume":"101","author":"Soci\u00e9","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.026_bib25","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/j.1600-6143.2008.02408.x","article-title":"Chronic kidney disease after hematopoietic cell transplantation: a systematic review","volume":"8","author":"Ellis","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2013.01.026_bib26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.bmt.1705446","article-title":"Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"38","author":"Reddy","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.026_bib27","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(02)08907-9","article-title":"Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease","volume":"359","author":"Biedermann","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2013.01.026_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","article-title":"Chronic graft-versus-host disease","volume":"9","author":"Lee","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.026_bib29","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bbmt.2010.08.023","article-title":"Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison","volume":"17","author":"Wang","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.026_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bcmd.2009.02.005","article-title":"HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation","volume":"43","author":"Chen","year":"2009","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.bbmt.2013.01.026_bib31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0360-3016(98)00077-7","article-title":"Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation","volume":"41","author":"Belkacemi","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2013.01.026_bib32","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1182\/blood-2011-01-329821","article-title":"Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius","volume":"117","author":"Soci\u00e9","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.01.026_bib33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1470-2045(09)70225-6","article-title":"Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial","volume":"10","author":"Finke","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2013.01.026_bib34","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.bmt.1704957","article-title":"Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group","volume":"35","author":"Basara","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.026_bib35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbmt.2005.12.034","article-title":"Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation","volume":"12","author":"Bacigalupo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.01.026_bib36","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/leu.2010.200","article-title":"Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Soci\u00e9te Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie Cellulaire","volume":"24","author":"Mohty","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.01.026_bib37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbmt.2010.08.012","article-title":"Evaluating the impact of antithymocyte globulin on lung function at 1 year after allogeneic stem cell transplantation","volume":"17","author":"Milano","year":"2011","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113000621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113000621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:44:15Z","timestamp":1761057855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879113000621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1083879113000621"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.01.026","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonmalignant Late Effects in Survivors of Partially Matched Donor Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}